Lixin Zhang

ORCID: 0000-0003-0894-9520 · 22 papers in corpus
other 2026
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2025.105215

RESEARCH QUESTION: Do iron metabolism and ferroptosis influence oocyte and embryo quality in patients with endometriosis undergoing IVF/intracytoplasmic sperm injection (ICSI), or in a mouse model? DESIGN: Fifty-seven patients with laparos…

2023
·doi:10.1158/1078-0432.c.6522953.v1

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

2023
·doi:10.1158/1078-0432.c.6522953

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

2023
·doi:10.1158/1078-0432.22455170.v1

Supplementary Materials and Methods

2023
·doi:10.1158/1078-0432.22455170

Supplementary Materials and Methods

2023
·doi:10.1158/1078-0432.22455191

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

2023
·doi:10.1158/1078-0432.22455191.v1

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

lab-animal 2023
·doi:10.1158/1078-0432.22455188.v1

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

lab-animal 2023
·doi:10.1158/1078-0432.22455188

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

2023
·doi:10.1158/1078-0432.22455185.v1

Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity

2023
·doi:10.1158/1078-0432.22455185

Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity

lab-animal 2023
·doi:10.1158/1078-0432.22455182

Suppl Fig S4. Complement and non-target siRNA

lab-animal 2023
·doi:10.1158/1078-0432.22455182.v1

Suppl Fig S4. Complement and non-target siRNA

2023
·doi:10.1158/1078-0432.22455179.v1

Suppl Table S1. Differentially expressed genes from different group comparisons

2023
·doi:10.1158/1078-0432.22455179

Suppl Table S1. Differentially expressed genes from different group comparisons

2023
·doi:10.1158/1078-0432.22455176

Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses

2023
·doi:10.1158/1078-0432.22455176.v1

Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses

2023
·doi:10.1158/1078-0432.22455173.v1

Suppl Table S3. Top five networks from different group comparisons, identified via Ingenuity Pathway Analyses

2023
·doi:10.1158/1078-0432.22455173

Suppl Table S3. Top five networks from different group comparisons, identified via Ingenuity Pathway Analyses

other 2022
Cancers ·doi:10.3390/cancers14225647

The immune tumor microenvironment (TME) of epithelial ovarian cancer (EOC) carries both effector and suppressive functions. To define immune correlates of chemotherapy-induced tumor involution, we performed longitudinal evaluation of biomar…

other 2014
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-14-1338

PURPOSE: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian tumors p…

lab-animal 2014
PloS one ·doi:10.1371/journal.pone.0102409

Activating mutations of Kras oncogene and deletions of Pten tumor suppressor gene play important roles in cancers of the female genital tract. We developed here new preclinical models for gynecologic cancers, using conditional (Cre-loxP) mi…